11 min read.Updated: 07 Dec 2021, 06:03 PM ISTJared S. Hopkins, The Wall Street Journal
Some therapies have been shown to work in clinical studies and other research
Within a few weeks, the US could have access to the first antiviral pills to treat Covid-19, either from Pfizer Inc. or Merck & Co. and partner Ridgeback Biotherapeutics LP. The Merck-Ridgeback drug, molnupiravir, received a positive recommendation on Nov. 30 from a panel of experts advising the Food and Drug Administration. The pill had been found in a late-stage study to cut the risk of hospitalization or death by about 30% in high-risk people with mild to moderate Covid-19. The U.K. cleared the drug for use earlier in November.